SCYNEXIS INC Business Finance Contracts & Agreements
42 Contracts & Agreements
- Assignment Agreements (2 contracts)
- Investor Rights Agreements (1)
- Loan Agreements (4)
- Note Agreements (3)
- Purchase Agreements (1)
- Registration Rights Agreements (1)
- Stock Agreements (16)
- Underwriting Agreements (6)
- Warrant Agreements (8)
- Form of Restricted Stock Award Grant Notice and Restricted Stock Award Agreement under the Amended and Restated 2015 Inducement Award Plan (Filed With SEC on November 9, 2022)
- Form of Pre-Funded Warrant (Filed With SEC on April 22, 2022)
- Form of Warrant (Filed With SEC on April 22, 2022)
- Equity Underwriting Agreement, dated April 22, 2022, by and between the Company and Guggenheim Securities, LLC, as representative of the several underwriters named on Schedule I... (Filed With SEC on April 22, 2022)
- Description of Common Stock (Filed With SEC on March 29, 2022)
- Form of Restricted Stock Unit Grant Notice and Award Agreement (Filed With SEC on February 8, 2022)
- Loan and Security Agreement, dated May 13, 2021, among the Company, Hercules Capital Inc., and Silicon Valley Bank (Filed With SEC on August 16, 2021)
- Description of Common Stock (Filed With SEC on March 29, 2021)
- Form of Series 1 and Series 2 Warrant (Filed With SEC on December 18, 2020)
- Form of Pre-Funded Warrant (Filed With SEC on December 18, 2020)
- Equity Underwriting Agreement, dated December 17, 2020, by and between the Company and Guggenheim Securities, LLC, as representative of the several underwriters named on Schedule... (Filed With SEC on December 18, 2020)
- SCYNEXIS, Inc. Amended and Restated 2014 Employee Stock Purchase Plan (Filed With SEC on August 10, 2020)
- SCYNEXIS, Inc. Amended and Restated 2009 Stock Option Plan (Filed With SEC on August 10, 2020)
- SCYNEXIS, Inc. Amended and Restated Stock Plan (Filed With SEC on August 10, 2020)
- Common Stock Purchase Agreement, dated April 10, 2020, between SCYNEXIS, Inc. and Aspire Capital Fund, LLC (Filed With SEC on April 13, 2020)
- Registration Rights Agreement, dated April 10, 2020, between SCYNEXIS, Inc. and Aspire Capital Fund, LLC (Filed With SEC on April 13, 2020)
- Senior Convertible Note Purchase Agreement, dated as of April 9, 2020, among SCYNEXIS, Inc., as Issuer, Puissance Life Science Opportunities Fund IV, as the Investor, (including... (Filed With SEC on April 9, 2020)
- Description of Common Stock (Filed With SEC on March 11, 2020)
- Form of Warrant (Filed With SEC on December 12, 2019)
- Underwriting Agreement, dated December 10, 2019, by and between the Company and H.C. Wainwright & Co., LLC, as representative of the several underwriters named on Schedule I... (Filed With SEC on December 12, 2019)
- SCYNEXIS, Inc. 2015 Inducement Award Plan, Adopted March 26, 2015, Amended June 9, 2015, and form of Stock Option Grant Notice and Stock Option Agreement (Filed With SEC on August 7, 2019)
- SCYNEXIS, INC., as Issuer, AND Puissance Life Science Opportunities Fund VI, as the Investor Senior Convertible Note Purchase Agreement Dated as of March 7, 2019 6.0% Convertible... (Filed With SEC on May 8, 2019)
- Second Amendment to Loan and Security Agreement between SCYNEXIS, Inc. and Solar Capital Ltd. dated March 30, 2018 (Filed With SEC on March 14, 2019)
- Senior Convertible Note Purchase Agreement, dated as of March 7, 2019, among SCYNEXIS, Inc., as Issuer, Puissance Capital Management, as the Investor, (including the form of Note... (Filed With SEC on March 8, 2019)
- First Amendment to Loan and Security Agreement between SCYNEXIS, Inc. and Solar Capital Ltd. dated March 30, 2018 (Filed With SEC on May 8, 2018)
- Form of Warrant (Filed With SEC on March 7, 2018)
- Equity Underwriting Agreement, dated March 6, 2018, by and between the Company and Guggenheim Securities, LLC, as representative of the several underwriters named on Schedule I... (Filed With SEC on March 7, 2018)
- WARRANT TO PURCHASE STOCK (Filed With SEC on October 5, 2016)
- LOAN AND SECURITY AGREEMENT (Filed With SEC on October 5, 2016)
- SCYNEXIS, INC. Warrant to Purchase Common Stock (Filed With SEC on June 22, 2016)
- 9,375,000 Shares of Common Stock ($0.001 Par Value) Warrants to Purchase up to 4,218,750 Shares of Common Stock SCYNEXIS, Inc. Common Stock EQUITY UNDERWRITING AGREEMENT (Filed With SEC on June 22, 2016)
- SCYNEXIS, INC. Up to$40,000,000 Shares of Common Stock (par value $0.001 per share) Controlled Equity OfferingSM Sales Agreement (Filed With SEC on April 11, 2016)
- ASSET PURCHASE AGREEMENT BY AND BETWEEN ACCURATUS LAB SERVICES, INC. (Buyer) AND SCYNEXIS, INC.(Seller) July 17, 2015 TABLE OF CONTENTS (Filed With SEC on July 23, 2015)
- [] Shares SCYNEXIS, Inc. Common Stock ($0.001 Par Value) EQUITY UNDERWRITING AGREEMENT (Filed With SEC on April 20, 2015)
- SCYNEXIS, INC. 2014 EMPLOYEE STOCK PURCHASE PLAN ADOPTED BY THE BOARD OF DIRECTORS: February 11,2014 APPROVED BY THE STOCKHOLDERS: February 25, 2014 (Filed With SEC on April 30, 2014)
- SCYNEXIS, INC. SERIESC-2 PREFERRED STOCK PURCHASE AGREEMENT (Filed With SEC on March 19, 2014)
- Dated 10 June 2005 (1) SCYNEXIS, Inc. -and - (2) C-CHEM AG Agreement forthe Assignment of Patents and Know How concerning Cyclosporin Derivatives 1 (Filed With SEC on March 19, 2014)
- SCYNEXIS, INC. 2014 EMPLOYEE STOCK PURCHASE PLAN ADOPTED BY THE BOARD OF DIRECTORS: February 11,2014 APPROVED BY THE STOCKHOLDERS: February 25, 2014 (Filed With SEC on March 19, 2014)
- SCYNEXIS, INC. FIFTHAMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT SCYNEXIS, INC. FIFTH AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (Filed With SEC on February 27, 2014)
- Dated 10 June 2005 (1) SCYNEXIS, Inc. -and - (2) C-CHEM AG Agreement forthe Assignment of Patents and Know How concerning Cyclosporin Derivatives 1 (Filed With SEC on February 27, 2014)